Article Information
History
- February 16, 2023.
Article Versions
- Version 1 (December 11, 2021 - 11:16).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK
- 2Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, UK
- 3MRC Biostatistics Unit, University of Cambridge, Cambridge UK
- ↵#Corresponding author; email: mk907{at}cam.ac.uk
↵* These authors contributed equally